- Home
- NWBI vs PVLA Comparison
NWBI vs PVLA Comparison
Compare NWBI & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWBI | PVLA |
|---|---|---|
| Founded | 1896 | 2015 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | NWBI | PVLA |
|---|---|---|
| Price | $12.42 | $112.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $13.67 | ★ $162.06 |
| AVG Volume (30 Days) | ★ 1.3M | 235.5K |
| Earning Date | 04-27-2026 | 05-14-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | ★ 16.46 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.29 | N/A |
| Revenue Next Year | $5.06 | N/A |
| P/E Ratio | $13.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.75 | $18.23 |
| 52 Week High | $13.62 | $151.18 |
Technical Indicators
Market Signals| Indicator | NWBI | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 46.19 |
| Support Level | $11.93 | $109.36 |
| Resistance Level | $12.91 | $147.47 |
| Average True Range (ATR) | 0.29 | 7.76 |
| MACD | 0.05 | -2.84 |
| Stochastic Oscillator | 44.67 | 8.85 |
Price Performance
Historical ComparisonAbout NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.